Form4insider filings, from the source

SEC Form 4 · accession 0000874015-16-000104

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Richard S Geary
Officer — SVP, Development
Period of report
Jan 15, 2016
Accepted (ET)
Jan 19, 2016 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2016M775$0.00A5,864D
Common StockF2Jan 19, 2016S309$41.4559D5,555D
Common StockF3Jan 15, 2016M1,397$0.00A6,952D
Common StockF4Jan 19, 2016S556$41.4674D6,396D
Common StockF5Jan 15, 2016M1,875$0.00A8,271D
Common StockF6Jan 19, 2016S747$41.4554D7,524D
Common StockF7Jan 15, 2016M1,380$0.00A8,904D
Common StockF8Jan 19, 2016S550$41.4573D8,354D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF9,F10—Jan 15, 2016A6,373A——Common Stock6,3736,373D
Restricted Stock UnitsF2,F9,F11—Jan 15, 2016M775D——Common Stock7750D
Restricted Stock UnitsF4,F9,F12—Jan 15, 2016M1,397D——Common Stock1,3971,397D
Restricted Stock UnitsF6,F9,F13—Jan 15, 2016M1,875D——Common Stock1,8753,750D
Restricted Stock UnitsF8,F9,F14—Jan 15, 2016M1,380D——Common Stock1,3804,138D

Explanation of responses